- Price
- $61.11
- Day
- +5.29%
- Mkt Cap
- $4.37B
- 52W Range
- $14.79 – $61.29
- Volume
- 2.18M
- Beta
- 0.26
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Avidity Partners Management LP increased its stake in Enliven Therapeutics, Inc. (NASDAQ: ELVN) by 185.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 400,000 shares of the company's stock after purchasing an additional 259,700 shares during the quarter. Enliven Therapeutics makes
Read full article